Document Classification

Section Type: RESULTS

Text: Prior to treatment patients with thyrotoxicosis were characterized by increased (P < 0. 05) levels of T3 (3. 75 + / - 0. 23 nmol/l (pretreatment), 1. 89 + / - 0. 08 (treated) and 1. 75 + / - 0. 11 (control)), resting energy expenditure (130. 5 + / - 3. 5 (pretreatment), 107. 7 + / - 2. 7 (treated) and 106. 3 + / - 3. 1 (control), % of predicted), protein oxidation (0. 67 + / - 0. 03 (pretreatment), 0. 54 + / - 0. 06 (treated) and 0. 46 + / - 0. 05 (control), mg/kg/min), lipid oxidation (1. 34 + / - 0. 08 (pretreatment), 1. 00 + / - 0. 06 (treated) and 1. 02 + / - 0. 04 (control), mg/kg/min), endogenous glucose production (2. 51 + / - 0. 13 (pretreatment), 1. 86 + / - 0. 12 (treated) and 1. 85 + / - 0. 12 (control), mg/kg/min), non-oxidative glucose turnover (1. 28 + / - 0. 16 (pretreatment), 0. 75 + / - 0. 18 (treated) and 0. 71 + / - 0. 11 (control), mg/kg/min) and a 50 % increase in total forearm blood flow.